Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




SmallCapVoice Featured Company: Proteonomix Inc. (PROT.PK)

QualityStocks (November 5th, 2008) Writes:

Proteonomix Inc. is a biotechnology company dedicated to the development of cell therapies to treat a wide variety of diseases. Headquartered in Mountainside, New Jersey, their current research is focused on cosmetics, antiaging, and injury. Through their subsidiary ProteoDERM, INC., they are commercializing their various products.

Their new line of anti-aging skin care products is now hitting the market. Their ProteoDERM Inc.’s anti-aging products are their Matrix NC-138 system of products. They sell the Matrix NC-138™ (3%) Serum, and a Day Cream SPF-25, Night Cream, a Gentle Cleanser, and a Gentle Exfoliator.

Proteonomix is also developing a platform for the growth of contaminant-free human embryonic stem (hES) cell lines. They will then make these available to the research community. They anticipate the commercialization of this product in the fourth quarter of this year. Proteonomix is working with leading scientists at prestigious institutions around the world to make tailored stem cell

...

Proteonomix Inc. (PROT.PK) is “One to Watch”

QualityStocks (October 7th, 2008) Writes:

Proteonomix Inc. is a biotechnology company dedicated to the development of cell therapies to treat a wide variety of diseases. Headquartered in Mountainside, New Jersey, their current research is focused on cosmetics, anti-aging, and injury. Through their subsidiary, ProteoDERM, INC., they are commercializing their various products.

Their new line of anti-aging skin care products is now hitting the market. These anti-aging products are the Matrix NC-138 system of products, sold as Matrix NC-138™ (3%) Serum, Day Cream SPF-25, Matrix Night Cream, a gentle cleanser and a gentle exfoliator.

Proteonomix is also developing a platform for the growth of contaminant-free human embryonic stem (hES) cell lines. They will then make these available to the research community. They anticipate the commercialization of this product in the fourth quarter of this year. Proteonomix is working with leading scientists at prestigious institutions around the world to make tailored stem cell therapies a reality.

The

...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.